Skip to content

Using the anterior capsule of the hip joint to protect the tensor fascia lata muscle during direct anterior total hip arthroplasty: a randomized controlled trial

Study for the technique of total hip arthroplasty through direct anterior approach

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025173
Enrollment
Unknown
Registered
2019-08-15
Start date
2018-03-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral neck fracture

Interventions

Group A:Use the anterior articular capsule to protect the tensor fascia lata muscle
Group B:The tensor fascia lata is not protected

Sponsors

The Affiliated Changzhou 2nd People's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
56 Years to 75 Years

Inclusion criteria

Inclusion criteria: From March 2018 to March 2019, 76 primary THAs were performed using the DAA by a single surgeon. The 76 patients, who ranged in age from 56 to 103 years old, suffered from femoral neck fractures and underwent an uncemented THA.

Exclusion criteria

Exclusion criteria: Of these patients, those patients older than 75 years were excluded. Patients with hepatic or renal failure, coagulation abnormalities, thrombosis, myocardial infarction, cerebrovascular accidents within the previous 6 months, or long-term use of anticoagulants were excluded. Patients who had surgery lasting more than 90 min or had an unexpected condition, such as an intraoperative fracture, were also excluded. In addition, patients who were unable to undergo an MRI because of claustrophobia and who could not be evaluated effectively by MRI were excluded.

Design outcomes

Primary

MeasureTime frame
blood hemoglobin;creatine phosphokinase;lactate dehydrogenase;myoglobin;visual analogue scores;Postoperative drainage volume;magnitude of changes in the muscle cross-sectional area;fatty atrophy;

Countries

China

Contacts

Public ContactYuji Wang

The Affiliated Changzhou 2nd People's Hospital of Nanjing Medical University

11958574@qq.com+86 13775221377

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026